May 25, 2013 05:24AM ET U.S. Markets Closed. S&P 500 +0.04% NASDAQ +0.03% Plans and Pricing

Abbott Laboratories (ABT)

Add to Watchlists Create an Alert

37.76 +0.28 +0.75% NYSE May 24, 8:00PM BATS Real time Currency in USD

Abbott Laboratories News

Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullback

May 23

Socially Minded Seniors Keep Co-Op Spirit Alive In Cambridge

May 23

AbbVie Price Boost of Drug Slammed in Studies Criticized

May 23

Abbott Laboratories: Undervalued Potential

May 23

CE Mark for Abbott's Xience Xpedition 48

May 22

A Moderate-Risk, High-Reward Dividend Play

May 22

CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog

Zacks May 22

Abbott Laboratories recently announced that it received CE Mark in Europe for its drug eluting stent -- Xience Xpedition 48 Everolimus Eluting Coronary Stent System

Abbott Laboratories' Management Presents at UBS Global Healthcare Conference (Transcript)

Seeking Alpha May 22

Abbott Laboratories (ABT) UBS Global Healthcare Conference Call May 22, 2013, 8:30 am ET Executives Brian Blaser - Executive Vice President - Diagnostics Products Thomas Freyman - Chief Financial Officer, ...

Abbott to Present at Deutsche Bank 38th Annual Health Care Conference

PR Newswire May 22

ABBOTT PARK, Ill., May 22, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) will participate in the Deutsche Bank 38 th Annual Health Care Conference on Wednesday, May 29, 2013. Thomas C. Freyman, executive vice ...